Backing Fertifa: reproductive healthcare for employers

Fertifa is a tech-enabled reproductive-healthcare provider helping employers support their employees through reproductive-health journeys. Fertifa fills a gap between the current offering of the private medical insurance market and the public health system.

Fertility is a largely underserved care need, people are increasingly considering having children later, and we saw in Fertifa the opportunity to fill some of this gap in a growing market.

Notable market trends within the fertility space

• Demographics: the need for fertility-related healthcare is directly linked with the growing age at which the population starts building a family.
• An employer’s problem: female and male fertility, menopause and broader reproductive-health topics increasingly impact the workplace. In the US, among large employers (>20,000 employees), only 23% do not cover any form of reproductive-health support.
• Clearly a private-health problem: the UK NHS serves only very specific conditions for fertility treatments, and even then waitlists range between 24 and 54 weeks.
• US precedents highly transferable to Europe: players like Maven Clinic and Carrot show traction with an employee-focused offering for reproductive health.

Where Fertifa comes in

Fertifa has built a tech-enabled solution to fill this gap in a scalable way, whilst distributing it through an innovative go-to-market strategy in Europe: selling their product and services to employers. Fertifa was founded in 2019 to provide impartial advice and wellbeing support to as many individuals as possible.

Fertifa has come across as the player in the market with the strongest clinical focus, whilst covering the broadest range of conditions. On top of its clinical support, Fertifa also has a tool to help employers manage fertility-benefit plans, demonstrating a clear ROI for large employers.

The team at Fertifa has demonstrated an impressive ability to execute and distribute its solution, whilst showing a true passion for the health outcomes the business creates, the perfect combination of performance and passion that motivates us at Triple Point as early-stage investors.